Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Pharma channel feed
Amgen and AstraZeneca share positive results in chronic rhinosinusitis
6 months ago
R&D
Eisai slashes Leqembi sales forecast by almost $100M
6 months ago
Pfizer to invest $1B in China over next five years — reports
6 months ago
Financing
China
Senior AstraZeneca exec detained in China amid wider investigation
6 months ago
People
China
Soft RSV sales reveal a vaccine market failing to catch post-Covid momentum
6 months ago
FDA+
FDA seeks to pull OTC nasal decongestant ingredient due to lack of efficacy
6 months ago
FDA+
Genmab chops early cancer prospects to prioritize Phase 3 projects
6 months ago
R&D
Gilead beats Covid drug sales forecasts, takes $1.75B hit on Trodelvy study fail
6 months ago
R&D
Moderna reports slow start to RSV sales as Bancel steps back from commercial role
6 months ago
People
California voters say yes to restrictions around 340B spending
6 months ago
FDA+
GSK CEO Emma Walmsley on the new Trump administration, trust, AI and China
6 months ago
People
China
CVS names Aetna head, plans more pharmacy closures as new CEO takes over
6 months ago
People
Health Tech
Novo unveils new cardiometabolic data as it reports solid third-quarter profits
6 months ago
R&D
Acadia lands $150M sale of rare pediatric PRV
6 months ago
FDA+
‘We’re good’ on weight loss: Biopharmas turn to muscle with new obesity drugs
6 months ago
Startups
R&D
Cerebral to pay nearly $3.7M over controlled substance prescribing practices
6 months ago
Startups
Health Tech
Zealand’s ‘aspirational’ mission for its amylin drug to be first-line in obesity
6 months ago
R&D
Updated: Vertex makes money from gene-edited therapy Casgevy
6 months ago
FDA cites Mark Cuban's drug compounding center in Dallas with sterility, quality concerns
6 months ago
FDA+
The election is Tuesday. What’s at stake for the pharma industry?
6 months ago
FDA+
BioNTech eases 2024 revenue outlook despite hefty Covid vaccine third-quarter sales
6 months ago
FDA expands faster drug review pilot from supplemental to full applications
6 months ago
FDA+
BioNTech says VEGF bispecific’s PD-L1 target, combo plans will be its edge
6 months ago
R&D
'We play to win': AstraZeneca details first results for oral GLP-1 and broader obesity ambitions
6 months ago
R&D
First page
Previous page
24
25
26
27
28
29
30
Next page
Last page